Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 43:445-452, doi:10.1016/j.jacc.2003.08.041
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, M. R.
Right arrow Articles by Redington, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, M. R.
Right arrow Articles by Redington, A.

Glucose-insulin infusion improves cardiac function during fetal tachycardia

Michael Rahbek Schmidt, MD*,*, Steen Buus Kristiansen, MD*, Paul White, PhD{dagger}, Morten Smerup, MD*, Hans Erik Bøtker, MD, PhD*, Michael Vogel, MD, PhD{ddagger}, Vibeke Hjortdal, MD, PhD, DMSc*, Keld Sørensen, MD* and Andrew Redington, MD, FRCP§

* Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark
{dagger} Papworth Hospital NHS Trust, Cambridge, Cambridgeshire, United Kingdom
{ddagger} Great Ormond Street Hospital for Sick Children, London, United Kingdom
§ Toronto Hospital for Sick Children, Toronto, Ontario, Canada



View larger version (10K):

[in a new window]
 
Figure 1 Examples of changes in left ventricular dP/dt in a control (left panel) and a glucose-insulin-treated (right panel) isolated heart in the Langendorff preparation. There is a progressive fall in dP/dtmax and rise in dP/dtmin throughout the 90-min pacing protocol in the control heart.

 


View larger version (21K):

[in a new window]
 
Figure 2 Box (in quartile range) and whisker (10th to 90th percentile) plot of systolic and diastolic performance of the isolated hearts in the control (left) and glucose-insulin (right) groups during 90 min of atrial pacing at 250 beats/min. Circles = outliers. LV = left ventricular.

 


View larger version (18K):

[in a new window]
 
Figure 3 Comparison of free myocardial content of free glycogen (shown as nmol/mg wet weight biopsy) in control and glucose-insulin (GI) groups in the three lines of experiments. *p < 0.005; #p < 0.01. Solid bars = control; open bars = GI.

 


View larger version (17K):

[in a new window]
 
Figure 4 Correlation between survival time and mean free myocardial glycogen content.

 


View larger version (16K):

[in a new window]
 
Figure 5 Comparison of fetal and neonatal force-frequency relationships (see Results for details). LV = left ventricular.

 


View larger version (37K):

[in a new window]
 
Figure 6 Individual fetal (in vivo) and neonatal systolic (dP/dtmax) and diastolic (tau) function during 90 min of pacing in controls (left panels) and glucose-insulin-treated (right panels) animals. Truncated curves illustrate premature death.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement